[NMusers] Modelling Scientist Opportunity at Novo Nordisk A/S

From: Henrik Agersø <HKAG>
Date: Tue, 13 Jan 2015 07:55:02 +0000


Modelling Scientist Opportunity at Novo Nordisk A/S

About the department
The Quantitative Clinical Pharmacology (QCP) department supports the entire=
 Novo Nordisk development portfolio with model-based analyses from first in=
 human trials to registration. We are a team of dedicated modelling scienti=
sts with an important role in the development of new drugs at Novo Nordisk =
as responsible for designing, analysing, interpreting, communicating and re=
porting quantitative clinical pharmacology information at all stages of cli=
nical drug development.

The job
As Modelling Scientist you will have an important role in the development o=
f new drugs at Novo Nordisk. You will be part of multidisciplinary project =
teams where you will be responsible for developing modelling analysis plans=
 for the project and follow them to completion. The position is located in =
Søborg, Denmark

Qualifications
You hold a university degree, e.g. statistics, engineering, pharmacy or oth=
er, preferably complemented by a PhD. You must have in depth understanding =
of pharmacokinetics/pharmacodynamics, statistical methodology, and data int=
erpretation as well as hands-on experience performing model-based analyses =
using S-PLUS/R and/or NONMEM. You are innovative with a high degree of inde=
pendence, result and quality oriented, and thrive in a continuously changin=
g environment with tight deadlines. You appreciate an informal atmosphere a=
nd act as a dedicated team player. As your colleagues will have different a=
cademic backgrounds, good presentation, communication and negotiation skill=
s are essential. You are fluent in English both orally and written.

At Novo Nordisk you will work with specialists from around the world. Our a=
mbitious teams work toward developing the next generation of care. As a gro=
wing organisation, we offer unique possibilities for personal and professio=
nal development, as well as a chance to work alongside the best in the fiel=
d.

Contact
For further information, please contact Henrik Agersø at +45 3079 3522

Apply at:
http://www.novonordisk.com/careers/job_section/jp.asp?jobid=26999BR&jobln=
g=uk&jobcnt=Denmark&type=1a

Deadline
31 January 2015.


___________________________________________________________________________=
__

Henrik Agersø, DVM, PhD
Director and Head of Quantitative Clinical Pharmacology
Global Development

Novo Nordisk A/S
Vandtårnsvej 108-110
DK-2860 Søborg
Denmark
+45 4444 8888 (phone)
+45 3079 3522 (mobile)
hkag_at_novonordisk.com
www.novonordisk.com<http://www.novonordisk.com>

Facebook<http://www.facebook.com/novonordisk> | Twitter<http://www.twitter.=
com/novonordisk> | LinkedIn<http://www.linkedin.com/company/novo-nordisk> |=
 Youtube<http://www.Youtube.com/novonordisk> | Pinterest<http://www.pintere=
st.com/novonordisk>

Changing the way we look at diabetes
A new DAWN for people with diabetes? Click here to read more<http://www.daw=
nstudy.com/>

This e-mail (including any attachments) is intended for the addressee(s) st=
ated above only and may contain confidential information protected by law. =
You are hereby notified that any unauthorized reading, disclosure, copying =
or distribution of this e-mail or use of information contained herein is st=
rictly prohibited and may violate rights to proprietary information. If you=
 are not an intended recipient, please return this e-mail to the sender and=
 delete it immediately hereafter. Thank you.

Received on Tue Jan 13 2015 - 02:55:02 EST

This archive was generated by hypermail 2.3.0 : Fri Sep 27 2019 - 16:42:38 EDT